Global Age-Related Macular Degeneration Market (2025-2031) | Strategy, Demand, Competition, Growth, Consumer Insights, Share, Companies, Supply, Size, Restraints, Analysis, Segmentation, Pricing Analysis, Value, Strategic Insights, Outlook, Segments, Drivers, Trends, Investment Trends, Opportunities, Industry, Forecast, Competitive, Revenue, Challenges

Market Forecast by Regions and Countries (North America, Europe, LATAM, Middle East, Asia and Africa), By Product (Eylea, Lucentis, Beovu, Others), By Disease Type (Dry AMD, Wet AMD), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC13245143 Publication Date: Apr 2025 Updated Date: Jul 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Bhawna Singh No. of Pages: 190 No. of Figures: 80 No. of Tables: 40

Global Age-Related Macular Degeneration Market Size & Growth Rate

According to 6Wresearch internal database and industry insights, the Global Age-Related Macular Degeneration Market was valued at USD 11.6 Billion in 2024 and is expected to reach USD 17.3 Billion by 2031, growing at a compound annual growth rate of 17.27% during the forecast period (2025-2031).

Global Age-Related Macular Degeneration Market Overview

The Global Age-Related Macular Degeneration (AMD) Market is experiencing growth driven by factors such as an aging population, increasing prevalence of AMD, advancements in diagnostic technologies, and rising awareness about eye health. The market is characterized by the presence of key players offering innovative treatments, including anti-VEGF drugs, supplements, and surgical interventions. Geographically, North America and Europe hold significant market shares due to well-established healthcare infrastructure and high adoption rates of advanced therapies. However, the Asia-Pacific region is expected to witness the fastest growth due to improving healthcare facilities, rising disposable incomes, and a growing geriatric population. Key trends in the market include personalized medicine approaches, telemedicine solutions, and ongoing research and development efforts to discover more effective treatments for AMD.

Global Age-Related Macular Degeneration Market Trends and Opportunities

The Global Age-Related Macular Degeneration (AMD) market is experiencing a shift towards innovative treatments such as gene therapy, stem cell therapy, and personalized medicine. The increasing elderly population, rising prevalence of AMD, and advancements in diagnostic technologies are driving market growth. Opportunities lie in the development of novel therapies targeting different stages of AMD, as well as the expansion of treatment options in emerging markets. Collaboration between pharmaceutical companies and research institutions for clinical trials and research projects is also on the rise. Additionally, the adoption of telemedicine and artificial intelligence in AMD diagnosis and management presents new avenues for market expansion. Overall, the AMD market is evolving rapidly, offering significant potential for growth and innovation in the coming years.

Global Age-Related Macular Degeneration Market Challenges

The Global Age-Related Macular Degeneration (AMD) market faces several challenges, including the high cost of treatment options, limited access to healthcare services in certain regions, and the increasing prevalence of AMD due to aging populations worldwide. Additionally, there is a need for more effective and targeted therapies for AMD, as current treatment options are not always successful in halting disease progression. The market also experiences challenges related to regulatory hurdles, such as lengthy approval processes for new drugs and treatments. Furthermore, the competitive landscape of the AMD market is intense, with multiple pharmaceutical companies vying for market share, leading to pricing pressures and the need for innovative strategies to differentiate products and reach patients effectively. Overall, addressing these challenges will be crucial for the continued growth and advancement of the Global AMD market.

Global Age-Related Macular Degeneration Market Drivers

The Global Age-Related Macular Degeneration (AMD) market is primarily driven by the increasing prevalence of AMD among the aging population, with the elderly being more susceptible to this condition. Technological advancements in diagnostic tools and treatment options, such as anti-VEGF drugs and gene therapy, are also driving market growth by improving patient outcomes and expanding the range of available treatment choices. Additionally, rising awareness about the importance of early detection and treatment of AMD, along with the growing demand for innovative therapies, are contributing to market expansion. Moreover, the increasing focus of pharmaceutical companies on developing novel drugs and therapies for AMD is expected to further propel market growth in the coming years.

Global Age-Related Macular Degeneration Market Government Policy

Government policies related to the Global Age-Related Macular Degeneration (AMD) Market primarily focus on promoting research and development initiatives, increasing access to AMD treatment options, and implementing measures to reduce the burden of AMD on healthcare systems. These policies often include funding support for AMD-related research projects, regulatory guidelines to ensure the safety and efficacy of AMD treatments, and reimbursement mechanisms to make AMD therapies more affordable for patients. Additionally, some countries may have specific programs to raise awareness about AMD and its risk factors, as well as initiatives to improve early diagnosis and management of the disease. Overall, government policies in the AMD market aim to address the growing prevalence of AMD, improve patient outcomes, and enhance the sustainability of healthcare systems in the face of an aging population.

Global Age-Related Macular Degeneration Market Future Outlook

The Global Age-Related Macular Degeneration (AMD) market is expected to witness steady growth in the coming years, driven by factors such as an aging population, increasing prevalence of AMD, advancements in diagnostic technologies, and the introduction of innovative treatment options. The market is likely to see a rise in research and development activities aimed at developing more effective therapies, including gene therapies and regenerative medicine approaches. Additionally, the growing awareness about eye health and the availability of government initiatives to improve access to AMD treatment are expected to further propel market growth. However, challenges such as high treatment costs and limited reimbursement coverage in some regions may hinder market expansion to a certain extent. Overall, the Global AMD market is poised for growth, with opportunities for companies to cater to the evolving needs of patients and healthcare providers.

Global Age-Related Macular Degeneration Market Regional Insights

In the global Age-Related Macular Degeneration (AMD) market, Asia is projected to witness significant growth due to the increasing aging population and rising prevalence of AMD in countries like Japan and China. North America is expected to dominate the market due to advanced healthcare infrastructure, high awareness about AMD, and the presence of key market players. Europe follows closely behind, driven by the growing adoption of advanced treatment options for AMD. The Middle East and Africa region is anticipated to show steady growth, supported by improving healthcare facilities and rising awareness about eye diseases. Latin America is also expected to witness growth due to increasing healthcare expenditure and the rising prevalence of AMD in countries like Brazil and Mexico. Overall, the global AMD market presents opportunities for growth across all regions, with varying degrees of market maturity and potential.

Key Highlights of the Report:

  • Global Age-Related Macular Degeneration Market Outlook
  • Market Size of Global Age-Related Macular Degeneration Market, 2024
  • Forecast of Global Age-Related Macular Degeneration Market, 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Revenues & Volume for the Period 2021 - 2031
  • Global Age-Related Macular Degeneration Market Trend Evolution
  • Global Age-Related Macular Degeneration Market Drivers and Challenges
  • Global Age-Related Macular Degeneration Price Trends
  • Global Age-Related Macular Degeneration Porter's Five Forces
  • Global Age-Related Macular Degeneration Industry Life Cycle
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Global Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of North America Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of United States of America Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Canada Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of North America Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Brazil Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Mexico Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Argentina Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of LATAM Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Asia Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of China Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of India Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Japan Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Asia Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Africa Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of South Africa Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Nigeria Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Egypt Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Africa Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Europe Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of United Kingdom Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of France Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Germany Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Europe Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Product for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Eylea for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Lucentis for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Beovu for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Disease Type for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Dry AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Wet AMD for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Hospital Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Specialty Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Middle East Age-Related Macular Degeneration Market Revenues & Volume By Online Pharmacy for the Period 2021 - 2031
  • Historical Data and Forecast of Saudi Arabia Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of UAE Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Turkey Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Historical Data and Forecast of Rest of Middle East Age-Related Macular Degeneration Market Revenues & Volume for the Period 2021 - 2031
  • Global Age-Related Macular Degeneration Market - Key Performance Indicators
  • Global Age-Related Macular Degeneration Market - Import Export Trade Statistics
  • Global Age-Related Macular Degeneration Market - Opportunity Assessment By Countries
  • Global Age-Related Macular Degeneration Market - Opportunity Assessment By Product
  • Global Age-Related Macular Degeneration Market - Opportunity Assessment By Disease Type
  • Global Age-Related Macular Degeneration Market - Opportunity Assessment By Distribution Channel
  • Global Age-Related Macular Degeneration Market - Top Companies Market Share
  • Global Age-Related Macular Degeneration Market - Top Companies Profiles
  • Global Age-Related Macular Degeneration Market - Comparison of Players in Technical and Operating Parameters
  • Global Age-Related Macular Degeneration Market - Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

The Global Age-Related Macular Degeneration Market size was valued USD 11.6 Billion in 2024 and is projected to reach USD 17.3 Billion by 2031.
The expected growth rate of the Global Age-Related Macular Degeneration Market is 17.27% during the forecast period.
6Wresearch actively monitors the Global Age-Related Macular Degeneration Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Global Age-Related Macular Degeneration Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Global Age-Related Macular Degeneration Market

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Global Age-Related Macular Degeneration Market Overview

3.1 Global Regional Macro Economic Indicators

3.2 Global Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F

3.3 Global Age-Related Macular Degeneration Market - Industry Life Cycle

3.4 Global Age-Related Macular Degeneration Market - Porter's Five Forces

3.5 Global Age-Related Macular Degeneration Market Revenues & Volume Share, By Regions, 2021 & 2031F

3.6 Global Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Global Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.8 Global Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 Global Age-Related Macular Degeneration Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Global Age-Related Macular Degeneration Market Trends

6 Global Age-Related Macular Degeneration Market, 2021 - 2031

6.1 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

6.1.1 Overview & Analysis

6.1.2 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Eylea, 2021 - 2031

6.1.3 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Lucentis, 2021 - 2031

6.1.4 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Beovu, 2021 - 2031

6.1.5 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Others, 2021 - 2031

6.2 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

6.2.1 Overview & Analysis

6.2.2 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Dry AMD, 2021 - 2031

6.2.3 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Wet AMD, 2021 - 2031

6.3 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

6.3.1 Overview & Analysis

6.3.2 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031

6.3.3 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Specialty Pharmacy, 2021 - 2031

6.3.4 Global Age-Related Macular Degeneration Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031

7 North America Age-Related Macular Degeneration Market, Overview & Analysis

7.1 North America Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

7.2 North America Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

7.2.1 United States (US) Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

7.2.2 Canada Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

7.2.3 Rest of North America Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

7.3 North America Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

7.4 North America Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

7.5 North America Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

8 Latin America (LATAM) Age-Related Macular Degeneration Market, Overview & Analysis

8.1 Latin America (LATAM) Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

8.2 Latin America (LATAM) Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

8.2.1 Brazil Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

8.2.2 Mexico Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

8.2.3 Argentina Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

8.2.4 Rest of LATAM Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

8.3 Latin America (LATAM) Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

8.4 Latin America (LATAM) Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

8.5 Latin America (LATAM) Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

9 Asia Age-Related Macular Degeneration Market, Overview & Analysis

9.1 Asia Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

9.2 Asia Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

9.2.1 India Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

9.2.2 China Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

9.2.3 Japan Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

9.2.4 Rest of Asia Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

9.3 Asia Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

9.4 Asia Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

9.5 Asia Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

10 Africa Age-Related Macular Degeneration Market, Overview & Analysis

10.1 Africa Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

10.2 Africa Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

10.2.1 South Africa Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

10.2.2 Egypt Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

10.2.3 Nigeria Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

10.2.4 Rest of Africa Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

10.3 Africa Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

10.4 Africa Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

10.5 Africa Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

11 Europe Age-Related Macular Degeneration Market, Overview & Analysis

11.1 Europe Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

11.2 Europe Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

11.2.1 United Kingdom Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

11.2.2 Germany Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

11.2.3 France Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

11.2.4 Rest of Europe Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

11.3 Europe Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

11.4 Europe Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

11.5 Europe Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

12 Middle East Age-Related Macular Degeneration Market, Overview & Analysis

12.1 Middle East Age-Related Macular Degeneration Market Revenues & Volume, 2021 - 2031

12.2 Middle East Age-Related Macular Degeneration Market, Revenues & Volume, By Countries, 2021 - 2031

12.2.1 Saudi Arabia Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

12.2.2 UAE Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

12.2.3 Turkey Age-Related Macular Degeneration Market, Revenues & Volume, 2021 - 2031

12.3 Middle East Age-Related Macular Degeneration Market, Revenues & Volume, By Product, 2021 - 2031

12.4 Middle East Age-Related Macular Degeneration Market, Revenues & Volume, By Disease Type, 2021 - 2031

12.5 Middle East Age-Related Macular Degeneration Market, Revenues & Volume, By Distribution Channel, 2021 - 2031

13 Global Age-Related Macular Degeneration Market Key Performance Indicators

14 Global Age-Related Macular Degeneration Market - Export/Import By Countries Assessment

15 Global Age-Related Macular Degeneration Market - Opportunity Assessment

15.1 Global Age-Related Macular Degeneration Market Opportunity Assessment, By Countries, 2021 & 2031F

15.2 Global Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F

15.3 Global Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F

15.4 Global Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

16 Global Age-Related Macular Degeneration Market - Competitive Landscape

16.1 Global Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024

16.2 Global Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters

17 Top 10 Company Profiles

18 Recommendations

19 Disclaimer

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 4,560
  • Department License
    $ 5,055
  • Site License
    $ 5,595
  • Global License
    $ 6,000
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Latest Reports

Industry Events and Analyst Meet

Whitepaper

Read All
Chat With 6W AI Intelligence